These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 26872817)
1. Concomitant presence of Aspergillus fumigatus and Stenotrophomonas maltophilia in the respiratory tract: a new risk for patients with liver disease? Cabaret O; Bonnal C; Canoui-Poitrine F; Emirian A; Bizouard G; Levesque E; Maitre B; Fihman V; Decousser JW; Botterel F J Med Microbiol; 2016 May; 65(5):414-419. PubMed ID: 26872817 [TBL] [Abstract][Full Text] [Related]
2. Case-control study of Stenotrophomonas maltophilia acquisition in cystic fibrosis patients. Marchac V; Equi A; Le Bihan-Benjamin C; Hodson M; Bush A Eur Respir J; 2004 Jan; 23(1):98-102. PubMed ID: 14738239 [TBL] [Abstract][Full Text] [Related]
3. Factors affecting the incidence of Stenotrophomonas maltophilia isolation in cystic fibrosis. Graff GR; Burns JL Chest; 2002 Jun; 121(6):1754-60. PubMed ID: 12065335 [TBL] [Abstract][Full Text] [Related]
4. Co-infection of the human cornea with Stenotrophomonas maltophilia and Aspergillus fumigatus. Cho BJ; Lee GJ; Ha SY; Seo YH; Tchah H Cornea; 2002 Aug; 21(6):628-31. PubMed ID: 12131049 [TBL] [Abstract][Full Text] [Related]
5. Risk factors for allergic bronchopulmonary aspergillosis and sensitisation to Aspergillus fumigatus in patients with cystic fibrosis. Ritz N; Ammann RA; Casaulta Aebischer C; Schoeni-Affolter F; Schoeni MH Eur J Pediatr; 2005 Sep; 164(9):577-82. PubMed ID: 15926067 [TBL] [Abstract][Full Text] [Related]
6. Risk factors for emergence of Stenotrophomonas maltophilia in cystic fibrosis. Talmaciu I; Varlotta L; Mortensen J; Schidlow DV Pediatr Pulmonol; 2000 Jul; 30(1):10-5. PubMed ID: 10862157 [TBL] [Abstract][Full Text] [Related]
7. Stenotrophomonas maltophilia in the respiratory tract of medical intensive care unit patients. Saugel B; Eschermann K; Hoffmann R; Hapfelmeier A; Schultheiss C; Phillip V; Eyer F; Laugwitz KL; Schmid RM; Huber W Eur J Clin Microbiol Infect Dis; 2012 Jul; 31(7):1419-28. PubMed ID: 22057419 [TBL] [Abstract][Full Text] [Related]
8. Association between glucose intolerance and bacterial colonisation in an adult population with cystic fibrosis, emergence of Stenotrophomonas maltophilia. Lehoux Dubois C; Boudreau V; Tremblay F; Lavoie A; Berthiaume Y; Rabasa-Lhoret R; Coriati A J Cyst Fibros; 2017 May; 16(3):418-424. PubMed ID: 28284526 [TBL] [Abstract][Full Text] [Related]
9. Investigation of Stenotrophomonas maltophilia epidemiology in a French cystic fibrosis center. Capaldo C; Beauruelle C; Saliou P; Rault G; Ramel S; Héry-Arnaud G Respir Med Res; 2020 Nov; 78():100757. PubMed ID: 32759054 [TBL] [Abstract][Full Text] [Related]
10. Pseudomonas aeruginosa Promotes Persistence of Stenotrophomonas maltophilia via Increased Adherence to Depolarized Respiratory Epithelium. McDaniel MS; Lindgren NR; Billiot CE; Valladares KN; Sumpter NA; Swords WE Microbiol Spectr; 2023 Feb; 11(1):e0384622. PubMed ID: 36472421 [TBL] [Abstract][Full Text] [Related]
11. Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease. Waters V; Yau Y; Prasad S; Lu A; Atenafu E; Crandall I; Tom S; Tullis E; Ratjen F Am J Respir Crit Care Med; 2011 Mar; 183(5):635-40. PubMed ID: 20889901 [TBL] [Abstract][Full Text] [Related]
12. Stenotrophomonas maltophilia: to be or not to be a cystic fibrosis pathogen. Hansen CR Curr Opin Pulm Med; 2012 Nov; 18(6):628-31. PubMed ID: 22990659 [TBL] [Abstract][Full Text] [Related]
13. Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis. Krzewinski JW; Nguyen CD; Foster JM; Burns JL J Clin Microbiol; 2001 Oct; 39(10):3597-602. PubMed ID: 11574579 [TBL] [Abstract][Full Text] [Related]
14. Life-threatening hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in the treatment of hematologic diseases. Mori M; Tsunemine H; Imada K; Ito K; Kodaka T; Takahashi T Ann Hematol; 2014 Jun; 93(6):901-11. PubMed ID: 24535696 [TBL] [Abstract][Full Text] [Related]
15. Independent predictors for mortality in patients with positive Stenotrophomonas maltophilia cultures. Kwa AL; Low JG; Lim TP; Leow PC; Kurup A; Tam VH Ann Acad Med Singap; 2008 Oct; 37(10):826-30. PubMed ID: 19037515 [TBL] [Abstract][Full Text] [Related]
17. Characteristics of Stenotrophomonas maltophilia bacteremia in children. Furuichi M; Ito K; Miyairi I Pediatr Int; 2016 Feb; 58(2):113-8. PubMed ID: 26139084 [TBL] [Abstract][Full Text] [Related]
18. Cooperativity between Stenotrophomonas maltophilia and Pseudomonas aeruginosa during Polymicrobial Airway Infections. McDaniel MS; Schoeb T; Swords WE Infect Immun; 2020 Mar; 88(4):. PubMed ID: 31932329 [No Abstract] [Full Text] [Related]
19. Co-infection of Pseudomonas aeruginosa and Stenotrophomonas maltophilia in hospitalised pneumonia patients has a synergic and significant impact on clinical outcomes. Yin C; Yang W; Meng J; Lv Y; Wang J; Huang B Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2231-2235. PubMed ID: 28669016 [TBL] [Abstract][Full Text] [Related]
20. Longitudinal study of Stenotrophomonas maltophilia antibody levels and outcomes in cystic fibrosis patients. Wettlaufer J; Klingel M; Yau Y; Stanojevic S; Tullis E; Ratjen F; Waters V J Cyst Fibros; 2017 Jan; 16(1):58-63. PubMed ID: 27346471 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]